IMMUNIC, INC.·4

Nov 23, 10:13 AM ET

Vitt Daniel 4

4 · IMMUNIC, INC. · Filed Nov 23, 2022

Insider Transaction Report

Form 4
Period: 2022-11-22
Vitt Daniel
DirectorCEO and Director
Transactions
  • Purchase

    Common Stock

    2022-11-22$1.35/sh+8,000$10,799376,877 total(indirect: See footnote)
Footnotes (1)
  • [F1]14,000 shares are owned directly by the Reporting Person and 362,877 shares are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares.

Documents

1 file
  • 4
    e618054_4-vitt.xmlPrimary